ArticleBMC veterinary research2026
Transcriptional effects of influenza virus M1 and NP gene expression in DF-1 cells and their immunogenicity in cognate B21 chickens.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundAlthough the influenza A virus (IAV) matrix protein 1 (M1) and nucleoprotein (NP) are attractive targets for cross-protective vaccines, their independent effects on host cell transcriptomes and subsequent immunogenicity in histocompatible hosts remain largely unexplored. Here, we utilized a previously established histocompatible DF-1 cell and a cognate B21 chicken (DF-1/B21) platform to characterize these interactions. Stable DF-1 cell lines expressing M1 or NP were analyzed via transcriptomic profiling and subsequently used as single-antigen vaccines.
resultsTranscriptional analysis revealed distinct host signatures: M1 expression was primarily associated with alterations in membrane-associated and cytoskeletal pathways. In contrast, NP expression was linked to the broad downregulation of DNA replication and cell cycle regulators, actin network reorganization, and the modulation of early innate signaling without inducing a full interferon response. Functional assays corroborated these findings, showing that despite higher viral susceptibility in M1-expressing cells, NP expression established a potent antiviral state characterized by reduced viral replication and an increase in pro-inflammatory (TNF-α, IL-6) and immune-recruiting (IL-15, IL-12p40) cytokines in vitro. NP, but not M1, was also spontaneously released into culture supernatants. In vivo, both vaccines elicited measurable humoral responses and reduced viral shedding upon H9N2 challenge. Furthermore, distinct shifts in peripheral CD8⁺/CD4⁺ ratios post-challenge indicated that both antigens effectively modulated cellular immunity.
conclusionsCollectively, these findings validate the DF-1/B21 system as a versatile platform for dissecting host–pathogen interactions. By effectively bridging cellular transcriptomics with systemic immunity, this histocompatible model offers a valuable framework for the broad evaluation of avian immunogens and the rational design of future poultry vaccines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.